For Immediate Release
Tanner Pharma Group
CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several international healthcare conferences throughout the upcoming months of March and April. The team will join other global executives for the following events:
Clinical Trial Supply Europe | March 13th – 14th | Milan, Italy
DCAT Week | March 18th – 21st | New York City, New York
PharmagoraPlus | March 30th – 31st | Paris, France
PQMD Global Health Policy Forum | April 16th – 18th | Geneva, Switzerland
US GCSG Conference | April 28th – May 1st | San Antonio, Texas
Tanner Pharma leverages more than 16 years of pharma services experience. The company provides services through four synergistic divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerMAP, managed access programs, TannerLAC, licensing, acquisition and commercialization; and TannerGAP, global access programs.
Our CTS, MAP and Corporate Development teams will be attending these events. Representatives include Graeme Birrell, TannerCTS Business Development Lead, Jonathan Bracey, Managing Director UK – SVP of Corporate Development, and Rob Keel, Director for TannerMAP.
Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
Shona John | email@example.com | +44 (0) 20 3940 8117
About Tanner Pharma Group
Tanner Pharma Group is a global service provider in the healthcare industry with a core purpose of improving lives through increased access to medicines. Each of its four service divisions is built on a foundation of a robust distribution network with industry-leading quality standards. Founded in 2003, the company works with a broad range of companies to distribute life-saving medications to patients in more than 120 countries. For more information about Tanner Pharma Group, please visit www.tannerpharma.com.
About Tanner Pharma Group
For over 16 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. By partnering with Tanner Pharma, biotech and pharma companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.
Tanner Pharma believes that access to medicines should have no borders and measures its value as a company based on the lives it helps to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus.
Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.